Strategic expand Cambridge Healthcare Research shows growth through its Solici strategic competitive intelligence division and Vox.Bio market research arm, indicating opportunity to cross-sell or expand offerings to clients seeking competitive insights, market intelligence, and commercialization strategy in pharma, biotech, and medical devices.

Leadership growth Recent executive appointments including a new Chief People Officer and a VP for US Commercial signal a focus on scaling, talent development, and regional market penetration, creating opportunities to position HR tech, performance analytics, and leadership development services.

Awarded credibility Queen’s Award for Enterprise achievement reinforces market credibility and demand for CHR’s services, suggesting sales leverage with risk-averse clients who value award-winning, high-quality consulting and advisory capabilities.

Hybrid access Hybrid working model and London HQ broaden the geographic and engagement flexibility for client delivery, enabling outreach to both UK/EU and US markets with scalable remote collaboration and blended service delivery packages.

CSR plus impact CHRs emphasis on societal impact and the CHR for Society initiative can be used to align with client CSR goals, offering partnerships or sponsorships that integrate social impact with life sciences initiatives as a differentiator in proposals.